Dynamic Advisor Solutions LLC Boosts Holdings in CVS Health Co. (NYSE:CVS)

Dynamic Advisor Solutions LLC lifted its position in shares of CVS Health Co. (NYSE:CVS - Free Report) by 92.7% in the first quarter, according to its most recent 13F filing with the SEC. The firm owned 37,013 shares of the pharmacy operator's stock after purchasing an additional 17,807 shares during the quarter. Dynamic Advisor Solutions LLC's holdings in CVS Health were worth $2,508,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of CVS. Whitebox Advisors LLC purchased a new position in CVS Health in the 4th quarter worth approximately $249,000. B&D White Capital Company LLC purchased a new position in CVS Health in the 4th quarter worth approximately $417,000. Fairfax Financial Holdings Ltd. Can purchased a new position in CVS Health in the 4th quarter worth approximately $121,742,000. Lazard Asset Management LLC boosted its holdings in CVS Health by 7.3% in the 4th quarter. Lazard Asset Management LLC now owns 4,290,953 shares of the pharmacy operator's stock worth $192,617,000 after acquiring an additional 293,406 shares during the period. Finally, Seizert Capital Partners LLC boosted its holdings in CVS Health by 22.8% in the 4th quarter. Seizert Capital Partners LLC now owns 569,527 shares of the pharmacy operator's stock worth $25,566,000 after acquiring an additional 105,708 shares during the period. Hedge funds and other institutional investors own 80.66% of the company's stock.

Insiders Place Their Bets

In related news, Director Guy P. Sansone bought 1,570 shares of the company's stock in a transaction on Thursday, June 5th. The shares were purchased at an average cost of $63.70 per share, with a total value of $100,009.00. Following the completion of the transaction, the director now directly owns 12,007 shares of the company's stock, valued at approximately $764,845.90. This represents a 15.04% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. 1.22% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

CVS has been the subject of a number of analyst reports. Robert W. Baird upped their price target on CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a report on Tuesday, April 15th. Morgan Stanley restated an "overweight" rating on shares of CVS Health in a report on Tuesday, April 15th. Truist Financial upped their target price on CVS Health from $82.00 to $84.00 and gave the company a "buy" rating in a research report on Monday, May 12th. Barclays set a $79.00 target price on CVS Health and gave the company an "overweight" rating in a research report on Monday, June 2nd. Finally, Wall Street Zen raised CVS Health from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Two analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average price target of $74.75.

CVS Health Stock Performance

CVS stock opened at $67.74 on Tuesday. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The firm has a market cap of $85.69 billion, a P/E ratio of 18.51, a P/E/G ratio of 0.98 and a beta of 0.56. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $72.51. The stock's 50 day simple moving average is $65.16 and its 200 day simple moving average is $60.21.

CVS Health (NYSE:CVS - Get Free Report) last issued its earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 earnings per share for the quarter, topping the consensus estimate of $1.62 by $0.63. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. The firm had revenue of $94.59 billion for the quarter, compared to analyst estimates of $93.07 billion. During the same period last year, the company earned $1.31 earnings per share. The firm's revenue for the quarter was up 7.0% on a year-over-year basis. As a group, equities research analysts predict that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.93%. The ex-dividend date of this dividend was Tuesday, April 22nd. CVS Health's dividend payout ratio is presently 63.48%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.